EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Beyond treatment response: Injection‐site reactions as part of the extended‐release buprenorphine experience

Julien Cabé iD, Georges Brousse

Addiction · 2026-09 · 121 (9) · 2575-2576

DOI: 10.1111/add.70496 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Addiction, online erschienen am 30.05.2026. Verfasst von Julien Cabé und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Addictology and Dual Disorders, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

involve a mixture of distressing and beneficial bodily experiences [12]. In that context, proactive explanation of possible local reactions may reduce anxiety, improve preparedness and support adherence. Prevention should therefore be considered part of routine care: strict subcutaneous administration, correct angle and depth of injection, site rotation and avoidance of local friction after injection are all simple but important measures [13, 14]. Early conservative management of mild reactions with cold compresses and standard analgesics, and of more moderate reactions with topical hydrocortisone and oral antihistamines, may help support treatment acceptability and maintain patient confidence [11]. Some published reports further suggest applying ice for 10 – 15 minutes before injection to reduce pain, and considering local analgesia when pain is more substantial [11, 13, 14]. If long-acting injectable buprenorphine is to achieve its full potential, injection-site reactions should not be framed primarily as a barrier to treatment uptake. Rather, they should be understood as predictable and usually manageable events that require good technique, patient education and early clinical attention. A clearer and more standardized approach to anticipating and managing these reactions may help preserve adherence and strengthen confidence in a treatment with substantial clinical benefit.

Schlagwörter

Stichwörter der Autor:innen

extended‐release buprenorphineinjection‐site reactionslong‐acting injectable treatmentopioid use disorderpatient experiencetreatment acceptability

Autor:innen und Institutionen

  • Department of Addictology and Dual Disorders, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
  • Clermont Auvergne University, Centre National de la Recherche Scientifique (CNRS), Clermont Auvergne Institut National Polytechnique (INP), Institut Pascal, Clermont-Ferrand, France.

ORCID-Profile: Julien Cabé

Zitieren

APA

Cabé, J., & Brousse, G. (2026). Beyond treatment response: Injection‐site reactions as part of the extended‐release buprenorphine experience. Addiction, 121(9), 2575-2576. https://doi.org/10.1111/add.70496

Vancouver

Cabé J, Brousse G. Beyond treatment response: Injection‐site reactions as part of the extended‐release buprenorphine experience. Addiction. 2026;121(9):2575-2576. doi:10.1111/add.70496

BibTeX
@article{Cab2026,
  author = {Cabé, Julien and Brousse, Georges},
  title = {Beyond treatment response: Injection‐site reactions as part of the extended‐release buprenorphine experience},
  journal = {Addiction},
  year = {2026},
  volume = {121},
  number = {9},
  pages = {2575--2576},
  doi = {10.1111/add.70496}
}
Kostenlos starten →